childhood supratentorial ependymoma
Showing 1 - 25 of 3,453
Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))
Active, not recruiting
- Malignant Glioma
- +2 more
- Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
- Concurrent Optune and RT followed by Optune System alone
-
Los Angeles, California
- +8 more
Jan 17, 2023
CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric
Recruiting
- Central Nervous System Tumor
- +10 more
- SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Ependymoma, Recurrent Childhood, Ependymoma Trial in Denver, Orlando (Granulocyte Macrophage Colony Stimulation Factor)
Active, not recruiting
- Ependymoma, Recurrent Childhood
- Ependymoma
- Granulocyte Macrophage Colony Stimulation Factor
-
Denver, Colorado
- +1 more
Feb 8, 2022
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,
Not yet recruiting
- Anaplastic Astrocytoma
- +17 more
- (no location specified)
Jun 28, 2023
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
Stored Tumor Samples in Young Patients With Brain Tumors
Recruiting
- Brain and Central Nervous System Tumors
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 5, 2022
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Anaplastic Ependymoma, Brain Ependymoma, Cellular Ependymoma Trial in Worldwide (radiation, drug, other)
Active, not recruiting
- Anaplastic Ependymoma
- +5 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +208 more
Mar 7, 2022
Childhood Ependymoma Trial in Worldwide (16 weeks of VEC + CDDP, VEC + HD-MTX, Chemotherapy + Valproate)
Recruiting
- Childhood Ependymoma
- 16 weeks of VEC + CDDP
- +6 more
-
Graz, Austria
- +39 more
Oct 6, 2021
CNS Tumor, Pediatric, Chemo-induced Nausea and Vomiting, Child Solid Tumor Trial in Canada, United States (Real Acupressure
Completed
- Central Nervous System Tumor, Pediatric
- +2 more
- Real Acupressure Band
- Placebo Acupressure Band
-
Long Beach, California
- +24 more
Jul 19, 2021
Childhood Brain Tumor Trial in Germany
Active, not recruiting
- Childhood Brain Tumor
-
Aachen, Germany
- +55 more
Apr 11, 2022
Rare CNS Tumors Outcomes &Risk
Recruiting
- High Grade Meningioma
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jul 6, 2022
Childhood Choroid Plexus Tumor, Childhood Medulloblastoma, Childhood Pineoblastoma Trial in Detroit (filgrastim)
Terminated
- Childhood Choroid Plexus Tumor
- +10 more
- filgrastim
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Oct 2, 2020
Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma Trial in United States (palbociclib
Terminated
- Childhood Choroid Plexus Tumor
- +18 more
- palbociclib isethionate
- +2 more
-
Los Angeles, California
- +10 more
Feb 10, 2021
Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
-
Birmingham, Alabama
- +113 more
Jun 28, 2022
Recurrent Childhood Medulloblastoma, Recurrent Ependymoma, Recurrent Medulloblastoma Trial in Houston (Laboratory Biomarker
Completed
- Recurrent Childhood Medulloblastoma
- +2 more
- Laboratory Biomarker Analysis
- Natural Killer Cell Therapy
-
Houston, TexasM D Anderson Cancer Center
Aug 31, 2020
Radioresistance of Ependymomas in Children and Adolescents
Recruiting
- Ependymoma of Brain
- Pediatric Solid Tumor
-
Toulouse, FranceInstitut Claudius Regaud
Dec 8, 2021
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)
Active, not recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- EGFR806-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Jan 18, 2023
Supratentorial Tumors, Malignant, Malignant Glioma, Glioblastoma Trial in Birmingham, Columbus (G207)
Active, not recruiting
- Supratentorial Neoplasms, Malignant
- +6 more
- G207
-
Birmingham, Alabama
- +1 more
Jun 1, 2022
Safety and Efficacy, Scalp Nerve Block Trial (a modified auriculotemporal nerve blockade, Traditional auriculotemporal nerve
Not yet recruiting
- Safety and Efficacy
- Scalp Nerve Block
- a modified auriculotemporal nerve blockade
- Traditional auriculotemporal nerve blockade
- (no location specified)
Sep 23, 2022
Ependymoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))
Terminated
- Ependymoma
- Antineoplaston therapy (Atengenal + Astugenal)
-
Houston, TexasBurzynski Clinic
Feb 18, 2022
Postoperative Analgesia, Quality of Recovery, Supratentorial Tumor Trial in Hangzhou (scalp nerve block)
Recruiting
- Postoperative Analgesia
- +4 more
- scalp nerve block
-
Hangzhou, Zhejiang, ChinaSecond affiliated Hospital School of Medicine,Zhejiang Universit
Nov 27, 2023